Alterity Therapeutics Ltd Stock Australian S.E.
Equities
AU000000PBT9
Biotechnology & Medical Research
Sales 2024 * | 1.87M 2.86M | Sales 2025 * | 1.39M 2.13M | Capitalization | 20.39M 31.26M |
---|---|---|---|---|---|
Net income 2024 * | -8M -12.26M | Net income 2025 * | -10M -15.33M | EV / Sales 2024 * | 10.9 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 14.7 x |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 86.93% |
Latest transcript on Alterity Therapeutics Ltd
Managers | Title | Age | Since |
---|---|---|---|
David Stamler
CEO | Chief Executive Officer | 63 | 17-04-30 |
Geoffrey Kempler
FOU | Founder | 69 | 97-11-10 |
Phillip Hains
DFI | Director of Finance/CFO | 64 | 14-04-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Geoffrey Kempler
FOU | Founder | 69 | 97-11-10 |
Peter Marks
BRD | Director/Board Member | 68 | 05-07-28 |
Lawrence Gozlan
BRD | Director/Board Member | 45 | 11-08-07 |
1st Jan change | Capi. | |
---|---|---|
+4.09% | 43.84B | |
+46.85% | 41.25B | |
+9.45% | 41.68B | |
-10.92% | 27.04B | |
+9.32% | 25.53B | |
-24.87% | 18.18B | |
+29.70% | 12.29B | |
+1.28% | 12.29B | |
+7.78% | 11.15B |